Navigation Links
eMetagens infectious disease technology licensed by WARF

MADISON - eMetagen announced Monday it has completed a license agreement with the Wisconsin Alumni Research Foundation to commercialize technology developed by Robert Goodman and collaborators at the University of Wisconsin-Madison over the past nine years.

Founded by Goodman, a UW profes......

Full article >>> 8,520 STTR Grant from the National Institutes of Health in March. The grant will fund research to find novel anti-bioweapon compounds in eMetagens natural product libraries. The company will begin operations at the McAllen T.E.C. Incubator on May 15th, 2004.

As a winner of the UW Business Schools Burrill Competition in 2001, Copaescu reflected on how the experience affected her work for ......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 05/05/04


Related biology technology :

1. Medical College receives $377K to study brain disease
2. Stem cells produce anti-disease protein in brain experiment
3. Neurognostics pushes early prediction of brain disease
4. ZyStor receives first funding and buys theraputics for rare diseases
5. Thompsons HHS legacy will include efforts to combat disease in Africa
6. Predictive medicine: Genes indicate diseases before symptoms do
7. FDA approves Bone Cares Hectorol for treatment of kidney disease
8. Symposium examines the effect of race on genetics and disease
9. HotMasterAn innovative Hot Start/Cold Stop technology for better PCR* results
10. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
11. GOP, Dems split over funding of state technology projects
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/16/2017)... 2017   Biostage, Inc. (Nasdaq: ... developing bioengineered organ implants to treat cancers and other ... today the closing on February 15, 2017 of its ... stock and warrants to purchase 20,000,000 shares of common ... offering was priced at $0.40 per share of common ...
(Date:2/16/2017)... , Feb. 16, 2017  Dermata Therapeutics, ... products to treat a variety of dermatological diseases, ... Series 1a financing and entered into a $5 ...  Dermata intends to use the capital for general ... major advancements in the treatment of serious diseases ...
(Date:2/16/2017)... Pa. , Feb. 16, 2017  Windtree ... biotechnology company focusing on developing aerosolized KL4 surfactant ... from a preclinical influenza study showed that aerosolized ... survival in a well-established preclinical animal model. The ... a growing body of evidence that supports the ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... extended its industry leading Biochemistry Services specifically targeting the rapidly growing needs ... methods for the biochemical and biosimilar characterization , product-related impurity characterization, ...
Breaking Biology Technology:
(Date:2/3/2017)... A new independent identity strategy consultancy firm announces its ... to fill a critical niche in technical and policy ... Mark Crego and Janice Kephart together ... that span federal governments, the 9/11 Commission, private industry, ... has a common theme born from a shared passion ...
(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, a ... emerging technology, announces the availability of a new report, Sensors ... Continue Reading ... ... and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets ...
(Date:1/26/2017)...  Acuity Market Intelligence today released the 2017 ...  Acuity characterizes 2017 as a "breakout" year for ... a new understanding of the potential benefits these ... identity are often perceived as threats to privacy ... of Acuity Market intelligence. "However, taken together these ...
Breaking Biology News(10 mins):